Journal of Multiple Sclerosis and Neuroimmunology

Previous issues

Page Path

HOME
BROWSE ARTICLES
Previous issue

Volume 15(2); Dec 2024

Review Articles

시신경척수염범주질환에서 Eculizumab의 치료적 역할: 김지은, 안석원; J Mult Scler Neuroimmunol. 2024;15(2):43-48. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.43-48; Full text PubReader ePub PDF

다발성경화증 환자들에서 Ocrelizumab의 임상적 유용성에 대한 고찰: 안석원; J Mult Scler Neuroimmunol. 2024;15(2):49-54. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.49-54; Full text PubReader ePub PDF

클라드리빈에대한종설(개발부터임상그리고실제치료에이르기까지): 신경진; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

Original Articles

난치중증근무력증 환자의 치료에 대한 권고합의안: 이형수, 정혜윤, 김승우, 손은희, 남태승, 신경진, 강사윤, 김현진, 박진성, 윤별아, 석흥열, 봉정빈, 정연경, 홍윤호, 신하영; J Mult Scler Neuroimmunol. 2024;15(2):59-71. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.59-71
Cited By 1; Full text PubReader ePub PDF

흉선종 재발과 중증근무력증 악화 사이의 시간적 연관성: 오병철, 신하영, 양영호, 김승우; J Mult Scler Neuroimmunol. 2024;15(2):72-80. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.72-80; Full text PubReader ePub PDF Supplementary Material

Case Report

단독 뇌간 및 척수 침범을 보인 MOG 항체 관련 질환 증례: 김예린, 채주희, 오선영; J Mult Scler Neuroimmunol. 2024;15(2):81-84. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.81-84; Full text PubReader ePub PDF

Neuroimage

미만성 경수막염으로 발현한 항-MOG 항체 연관질환: 김준순; J Mult Scler Neuroimmunol. 2024;15(2):85-86. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.85-86
Cited By 1; Full text PubReader ePub PDF

Volume 15, No. 2

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

3,353	Autoimmune Nodopathy: When to Suspect and How to Treat?
3,018	National Consensus Guidance for Management of Refractory Myasthenia Gravis
2,111	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
1,957	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
1,519	Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Cited By 1	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.